These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25394209)

  • 21. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
    Katano K; Kawano M; Koni I; Sugai S; Muro Y
    J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
    Levy Y; Sherer Y; Ahmed A; Langevitz P; George J; Fabbrizzi F; Terryberry J; Meissner M; Lorber M; Peter JB; Shoenfeld Y
    Lupus; 1999; 8(9):705-12. PubMed ID: 10602441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The diagnostic value of anti-SSA antibody in primary Sjögren's syndrome].
    Li MT; Zhao Y; Zheng WJ; Su JM; Wu QJ; Jiang Y; Xu D; Zhang W; Zhang FC; Dong Y
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):410-3. PubMed ID: 20646416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare autoantibodies to cellular antigens in systemic lupus erythematosus.
    Fredi M; Cavazzana I; Quinzanini M; Taraborelli M; Cartella S; Tincani A; Franceschini F
    Lupus; 2014 Jun; 23(7):672-7. PubMed ID: 24557777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A man with skin lesions of his face].
    Mutsaers ER; Kloppenburg G; Lavrijsen AP
    Ned Tijdschr Geneeskd; 2016; 160():A9980. PubMed ID: 27353155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal lupus erythematosus with cholestatic hepatitis.
    Lin SC; Shyur SD; Huang LH; Wu JY; Chuo HT; Lee HC
    J Microbiol Immunol Infect; 2004 Apr; 37(2):131-4. PubMed ID: 15181498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
    Castellino G; Corallini F; Trotta F; Secchiero P
    Lupus; 2007; 16(7):479-82. PubMed ID: 17670845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IVIG--mechanisms of action.
    Simon HU; Späth PJ
    Allergy; 2003 Jul; 58(7):543-52. PubMed ID: 12823109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice.
    Krause I; Blank M; Shoenfeld Y
    J Clin Immunol; 1998 Jan; 18(1):52-60. PubMed ID: 9475354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and identification of antinuclear autoantibodies in the serum of normal blood donors.
    de Vlam K; De Keyser F; Verbruggen G; Vandenbossche M; Vanneuville B; D'Haese D; Veys EM
    Clin Exp Rheumatol; 1993; 11(4):393-7. PubMed ID: 8403584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population.
    Li X; Liu X; Cui J; Song W; Liang Y; Hu Y; Guo Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22965. PubMed ID: 31313384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg).
    Ronda N; Haury M; Nobrega A; Coutinho A; Kazatchkine MD
    Clin Immunol Immunopathol; 1994 Feb; 70(2):124-8. PubMed ID: 8299227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of squamous cell carcinoma in chronic discoid lupus erythematosus: a report of two patients with anti-Ro/SSA antibodies.
    Miyagawa S; Minowa R; Yamashina Y; Ohi H; Shira T
    Lupus; 1996 Dec; 5(6):630-2. PubMed ID: 9116710
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaphylaxis to IVIG.
    Williams SJ; Gupta S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):11-19. PubMed ID: 27412077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis.
    Boonyaleepun S; Boonyaleepun C; Schlactus JL
    Asian Pac J Allergy Immunol; 1999 Mar; 17(1):59-62. PubMed ID: 10403010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iatrogenic ANA: An emerging source of expensive diagnostic confusion.
    Ali H; Buechler CR; Sanaullah O; Lucas A; Lohr KL
    Lupus; 2023 Feb; 32(2):299-300. PubMed ID: 36473694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital.
    Banhuk FW; Pahim BC; Jorge AS; Menolli RA
    Autoimmune Dis; 2018; 2018():9856910. PubMed ID: 30364021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous immunoglobulins on in vitro immunoglobulin formation in patients with antibody immunodeficiency.
    Krátká Z; Bártová J; Krystůfková O; Benetková K; Mrklas L; Fucíková T
    APMIS; 2002 Mar; 110(3):205-13. PubMed ID: 12076273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.